Global HLA Typing Market Report 2022: Increasing Number of Organ Transplants Drives Growth – ResearchAndMarkets.com

Global HLA Typing Market Report 2022: Increasing Number of Organ Transplants Drives Growth – ResearchAndMarkets.com




Global HLA Typing Market Report 2022: Increasing Number of Organ Transplants Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “HLA Typing Market by Product, Technology, Application, End User, and Geography – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The Global HLA Typing Market is expected to grow at a CAGR of 5.6% from 2022 to 2029 to reach $1.90 billion by 2029.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth in the HLA typing market is attributed to the increasing number of organ transplants and technological advancements in the molecular assays used for HLA typing. In addition, the increasing awareness amongst people regarding organ donations offers a growth opportunity for the HLA typing market.

Based on product, in 2022, the consumables segment is estimated to account for the largest share of the HLA typing market. High demand for consumables, availability of diverse consumables, and companies focused on launching new HLA typing consumables contribute to the growth of this segment. For instance, in 2020, Omixon Inc. (U.S.) launched an 11-locus multiplex HLA genotyping assay.

Based on technology, in 2022, the molecular technologies segment is estimated to account for the largest share of the HLA typing market. Advancements and benefits of molecular technologies compared to non-molecular technologies contribute to the large share of this segment.

Based on application, in 2022, the diagnostics segment is expected to account for the largest share of the HLA typing market. The high prevalence of chronic and metabolic diseases leading to organ failures is responsible for the largest segment share. The application of HLA typing for donor-recipient cross-matching, infectious disease pathogenesis, and transfusion is rising, contributing to the largest segment share.

Based on end user, in 2022, the diagnostic laboratories segment is estimated to account for the largest share of the HLA typing market. HLA typing products are frequently used in diagnostics laboratories for disease diagnosis and donor-recipient cross-matching. Outsourcing laboratory services by hospitals and transplant centers and consolidating diagnostics laboratories contribute to the large share of this segment. The partnerships or outsourcing of laboratory services provides benefits such as cost savings, efficiency gains, and the right allocation of resources. Thus, the increasing collaboration between hospitals/transplant centers with diagnostic laboratories results in adoption of HLA typing products by diagnostic laboratories.

An in-depth analysis of the geographical scenario of the HLA typing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2022, North America is estimated to account for the largest share of the HLA typing market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The highest number of organ transplants, high prevalence of chronic diseases, high spending on healthcare, and well-established healthcare infrastructure are the primary factors responsible for the large share of the North American HLA typing market.

Market Dynamics

Drivers

  • Increasing Number of Organ Transplants
  • Technological Advancements in HLA Typing

Restraints

  • High Cost of Instruments Required to HLA Typing

Opportunities

  • Increasing Awareness Regarding the Importance of Organ Donations

Challenges

  • Gap Between Organ Donations and Organ Receivers 

Scope of the Report:

HLA Typing Market, by Product

  • Consumables
  • Instruments
  • Software & Services

HLA Typing Market, by Technology

  • Molecular Technologies
  • PCR-based Molecular Techniques
  • Sequence-specific Primers
  • Sequence-specific Oligonucleotide
  • Other PCR-based Molecular Techniques
  • Other PCR-based molecular techniques include RPLF-PCR, SNP-PCR, and PCR-SSCP.
  • Sequencing-based Molecular Technologies
  • Sangers Sequencing
  • Next-generation Sequencing
  • Pyrosequencing
  • DNA Microarray
  • Non-molecular Technologies

HLA Typing Market, by Application

  • Diagnostics
  • Donor Recipient Cross-matching
  • Transfusion Therapy
  • Other Diagnostic Applications
  • Other diagnostic applications include Autoimmune Disease Diagnosis, Cancer Diagnosis, Infectious Disease Testing and Paternity testing.
  • Research

HLA Typing Market, by End Users

  • Diagnostics Laboratories
  • Hospitals & Transplant Centers
  • Academic & Research Institutes

HLA Typing Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLA)
  • Middle East & Africa

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Global HLA Typing Market, by Product

6. Global HLA Typing Market, by Technology

7. Global HLA Typing Market, by Application

8. Global HLA Typing Market, by End User

9. HLA Typing Market, by Geography

10. Competitive Landscape

11. Company Profiles (Business Overview, Financial Snapshot, Product Benchmarking, and Strategic Developments)

12. Appendix

Companies Mentioned

  • Thermo Fisher Scientific Inc. (U.S.)
  • Bio-Rad Laboratories (U.S.)
  • Qiagen N.V. (Netherlands)
  • Genome Diagnostics B.V. (GenDx) (Netherlands)
  • Illumina Inc. (U.S.)
  • CareDx (U.S.)
  • Immucor Inc. (U.S.)
  • TBG Diagnostics Limited (Australia)
  • BAG Diagnostic GmbH (Germany)
  • Omixon Inc. (Hungary)
  • Luminex Corporation (U.S.)
  • inno-train Diagnostik GmbH (Germany)
  • Pacific Biosciences of California Inc. (U.S.)
  • Fujirebio Holdings Inc. (Japan)

For more information about this report visit https://www.researchandmarkets.com/r/wyv2nm

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900